Vibroacoustic Therapy for Respiratory Failure Due to Hip Fracture
The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs
Recruiting
N/AInterventional Study
VibrationRespiratory Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
60 – 85
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
60 (estimated)
Sponsor
Astana Medical University · Other
Who this trial is looking for
This trial is looking for older patients with hip fractures who are experiencing breathing problems. Participants will receive vibroacoustic therapy for their lungs over 5 days, which does not require much active effort from them.
Are You a Good Fit for This Trial?
Rules you outAcute respiratory failureSevere decompensated diseases
You may be able to join if
I have respiratory failure
I have a hip fracture
My Injury Severity Score is no higher than 8
You may not be able to join if
I have a terminal condition
I am in shock
I have abnormal breathing patterns
I have a severe high blood pressure emergency
I have very low blood clotting risks
I have very high blood clotting risks
I had a stroke in the last few days
I have unstable rib fractures
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
A medical professional trained in the procedure and use of the device will conduct the vibroacoustic therapy session. He will also take blood samples.
In the control group, patients will undergo vibroacoustic pulmonary therapy in the "Pneumonia" mode, and in the control group, in the "Prevention" mode. Vibroacoustic pulmonary therapy will be conducted over a period of 5 days. A similar algorithm …
A medical professional trained in the procedure and use of the device will conduct the vibroacoustic therapy session. He will also take blood samples.
In the control group, patients will undergo vibroacoustic pulmonary therapy in the "Pneumonia" mode, and in the control group, in the "Prevention" mode. Vibroacoustic pulmonary therapy will be conducted over a period of 5 days. A similar algorithm of actions is planned for both groups. VALT sessions will be conducted 4-6 times a day for 5 minutes in combination with treatment according to the protocol for the use of "Vibroacoustic Therapy" of the lungs of the Ministry of Health of the Republic of Kazakhstan. The device's emitters will be applied to the affected areas of the lungs. Since the device has long cords for the emitters and is portable, it is not difficult to change the patient's position and does not require their active participation, which is important for patients on ventilators and with limited mobility.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
* respiratory failure;
* hip fracture;
* Injury Severity Score no higher than 8 points.
Exclusion Criteria:
* All contraindications for use of the device:
* terminal condition of the patient;
* shock;
* paradoxical pathological breathing;
* hypertensive crisis;
* severe hypocoagulation with a risk…
* respiratory failure;
* hip fracture;
* Injury Severity Score no higher than 8 points.
Exclusion Criteria:
* All contraindications for use of the device:
* terminal condition of the patient;
* shock;
* paradoxical pathological breathing;
* hypertensive crisis;
* severe hypocoagulation with a risk of hematoma formation or bleeding in the projection of exposure;
* severe hypercoagulation, risk of thrombus/embolus migration along the main vessels in the area of exposure;
* acute cerebrovascular accident in the first 1-3 days;
* brain edema;
* presence of multiple purulent or burn wound surfaces in the area of exposure;
* presence of unstable rib fractures;
* pneumomediastinum and/or subcutaneous emphysema of the chest;
* osteomyelitis of the ribs and/or thoracic spine;
* spinal fracture without orthopedic fixation;
* chest or abdominal trauma with bleeding;
* Injury Severity Score greater than 8 points;
* concomitant diseases in the stage of decompensation.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.